Interleukin-6 in cerebrospinal fluid as a biomarker of acute meningitis

Abstract

Background Microbiological culture of cerebrospinal fluid is the gold standard to differentiate between aseptic and bacterial meningitis, but this method has low sensitivity. A fast and reliable new marker would be of interest in clinical practice. Objective Interleukin-6, secreted by T cells in response to meningeal pathogens and quickly delivered into cerebrospinal fluid, was evaluated as a marker of acute meningitis. Design and Methods A total of 150 cerebrospinal fluid samples were analysed by an electrochemiluminescence method, selected according to patient diagnosis: (a) bacterial meningitis confirmed by positive culture ( n = 26); (b) bacterial meningitis with negative culture or not performed ( n = 15); (c) viral meningitis confirmed by polymerase chain reaction or immunoglobulin G determination ( n = 23); (d) viral meningitis with polymerase chain reaction negative or not performed ( n = 42); and (e) controls ( n = 44). Results Cerebrospinal fluid interleukin-6 concentration showed significant differences between all pathologic groups and the control group ( P < 0.001). As a diagnostic tool for bacterial meningitis, interleukin-6 showed an area under the curve of 0.937 (95% confidence intervals: 0.895–0.978), significantly higher than those of classical biomarkers. An interleukin-6 cutoff of 1418 pg/mL showed 95.5% sensitivity and 77.5% specificity, whereas a value of 15,060 pg/mL showed 63.6% sensitivity and 96.7% specificity, for diagnosis of bacterial meningitis. Conclusion Interleukin-6 measured by electrochemiluminescence method is a promising marker for early differentiation between aseptic and bacterial meningitis. More studies are needed to validate clinical implications for future practice in an emergency laboratory.